Mpox, formerly known as monkeypox, is a rare viral disease that has gained global attention in recent years due to outbreaks outside of its typical regions. While usually self-limiting, mpox can sometimes lead to serious complications, making awareness and preventive measures essential.
What Is Mpox?
Mpox is a viral zoonotic disease, meaning it can spread from animals to humans. It is caused by the mpox virus, which is related to the virus that causes smallpox, though mpox is generally less severe.
The disease was first identified in laboratory monkeys in 1958 (hence the name), and the first human case was recorded in 1970 in the Democratic Republic of the Congo. Mpox primarily occurs in central and western African countries but has spread to other parts of the world in recent outbreaks.
Symptoms of Mpox
Symptoms typically appear 5 to 21 days after exposure and can include:
- Fever
- Headache
- Muscle aches and back pain
- Swollen lymph nodes
- Chills and exhaustion
- A distinctive rash that often starts on the face and spreads to other parts of the body, including the genitals
- The rash progresses from flat lesions to raised bumps, then to fluid-filled blisters that eventually scab over and fall off.
How Is Mpox Spread?
Mpox can be transmitted in several ways:
- Direct contact with the rash, scabs, or body fluids of an infected person
- Prolonged face-to-face contact, leading to respiratory droplet exposure
- Touching contaminated materials (e.g., clothing, bedding)
- Contact with infected animals, through bites, scratches, or meat preparation
Prevention of Mpox
Preventive strategies are key to controlling the spread of mpox, especially during outbreaks. These include:
1. Avoid Close Contact
Avoid physical contact with people who have a rash or are suspected of having mpox.
Do not share personal items like bedding, towels, or utensils with infected individuals.
2. Practice Good Hygiene
Wash hands frequently with soap and water or use alcohol-based hand sanitizer.
Disinfect surfaces and objects that may be contaminated.
3. Use Protective Equipment
Healthcare workers and caregivers should use personal protective equipment (PPE) when treating mpox patients.
4. Wear a Mask
Wearing a mask is important, especially when in close proximity to someone who may be infected. Mpox can spread through respiratory droplets during prolonged face-to-face contact, particularly in indoor settings or crowded environments.
Use a well-fitting medical or N95 mask if caring for or interacting with someone with suspected or confirmed mpox.
In healthcare settings and during outbreaks, mask usage is a key part of infection prevention protocols.
5. Vaccination
A vaccine originally developed for smallpox, called JYNNEOS (also known as Imvamune or Imvanex), has been approved for use against mpox. It can be used both as:
Pre-exposure prophylaxis for people at higher risk
Post-exposure vaccination to reduce severity if given within 4 days of exposure
Treatment of Mpox
Most mpox cases are mild and self-limiting, resolving within 2 to 4 weeks. However, some individuals, especially those with weakened immune systems or underlying health conditions, may experience more severe illness.
Supportive Care
- Fluids and pain relievers to manage symptoms
- Antihistamines or topical creams for itching and rash relief
- Antiviral Medications
In severe cases or for those at risk of complications, antiviral drugs may be used, such as: - Tecovirimat (TPOXX) – an antiviral originally developed for smallpox, shown to be effective against mpox
- Cidofovir and Brincidofovir – may be considered in specific cases
Isolation
Infected individuals should isolate until all scabs have fallen off and a new layer of skin has formed to prevent transmission.
Conclusion
Mpox is a serious but manageable viral infection. With proper hygiene, awareness, mask use, and access to vaccines and treatment, its spread can be significantly reduced. Public health efforts remain focused on early detection, isolation of cases, and community education to keep outbreaks under control.
